Neko Health raises $700 million to expand AI body scans in the US
$700M. Neko Health just bet big on AI-powered preventive screening—and it's coming to your neighborhood.

Why it matters
A major Series C signals investor conviction in AI-driven healthcare diagnostics as a defensible, high-margin business model. This isn't a model release or feature drop—it's capital flowing toward applied AI in regulated verticals.
The key facts
5 to know$700M Series C funding round
Led by Lightspeed Venture Partners, co-led by O.G. Venture Partners
US expansion starting with New York clinic
Service combines medical imaging, blood tests, proprietary sensors, clinician review
Preventive screening use case
Go to the source
AI Newsartificialintelligence-news.com
Publisher excerpt: Neko Health has raised $700 million to expand its AI body scans in the United States, starting with a clinic in New York. The company’s preventive screening service combines medical imaging, blood tests, proprietary sensors, and clinician review. The Series C round was led by Lightspeed Venture…